Results
1 -
10 of
14New drug development for pediatric oncology, Investigational New Drugs Phase II study of fazarabine in advanced head and neck cancer, Investigational New Drugs Phase I trial of a 72-h continuous-infusion schedule of fazarabine, Cancer Chemotherapy and Pharmacology Cellular metabolism of 1-??-d-arabinofuranosyl-5-azacytosine and incorporation into DNA and RNA of human lymphoid CEM/0 and CEM/dCk(???) cells, Cancer Chemotherapy and Pharmacology A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study, Cancer Chemotherapy and Pharmacology Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate, Investigational New Drugs A phase I trial of fazarabine in refractory pediatric solid tumors, Investigational New Drugs Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer, Investigational New Drugs Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma, Investigational New Drugs Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer, Investigational New Drugs